Total Payments
$207,610
2024 Payments
$3,160
Companies
72
Transactions
2,117
Medicare Patients
5,583
Medicare Billing
$1.5M
Payment Breakdown by Category
Other$126,331 (60.9%)
Food & Beverage$32,444 (15.6%)
Consulting$27,118 (13.1%)
Travel$21,432 (10.3%)
Education$285.93 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $116,781 | 74 | 56.3% |
| Food and Beverage | $32,444 | 1,954 | 15.6% |
| Consulting Fee | $27,118 | 18 | 13.1% |
| Travel and Lodging | $21,432 | 57 | 10.3% |
| Honoraria | $9,550 | 6 | 4.6% |
| Education | $285.93 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $42,706 | 139 | $0 (2024) |
| GENZYME CORPORATION | $37,463 | 117 | $0 (2023) |
| ABBVIE INC. | $26,866 | 105 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $24,967 | 159 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $14,932 | 29 | $0 (2018) |
| Allergan, Inc. | $11,388 | 42 | $0 (2021) |
| SK Life Science, Inc. | $9,161 | 43 | $0 (2024) |
| UCB, Inc. | $8,890 | 163 | $0 (2024) |
| Biogen, Inc. | $7,403 | 189 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $6,056 | 81 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,160 | 183 | UCB, Inc. ($520.10) |
| 2023 | $12,065 | 282 | ABBVIE INC. ($5,622) |
| 2022 | $27,661 | 259 | EISAI INC. ($10,113) |
| 2021 | $20,411 | 283 | AbbVie Inc. ($11,606) |
| 2020 | $22,553 | 267 | Allergan, Inc. ($9,499) |
| 2019 | $25,060 | 288 | EISAI INC. ($11,102) |
| 2018 | $48,232 | 273 | GENZYME CORPORATION ($16,962) |
| 2017 | $48,467 | 282 | Bayer HealthCare Pharmaceuticals Inc. ($9,930) |
All Payment Transactions
2,117 individual payment records from CMS Open Payments — Page 1 of 85
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Neurology | ||||||
| 09/23/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.30 | General |
| 09/21/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Neurology | ||||||
| 09/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: EPILEPSY | ||||||
| 09/18/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Neurology | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Neurology | ||||||
| 09/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $26.05 | General |
| Category: NEUROLOGY | ||||||
| 09/12/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 09/11/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Neurology | ||||||
| 09/10/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $32.66 | General |
| Category: Neurology | ||||||
| 09/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Neuroscience | ||||||
| 09/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Neuropsychiatry | ||||||
| 09/05/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Adenosine A2A Receptors | ||||||
| 09/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.31 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Neurology | ||||||
| 08/28/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $8.01 | General |
| 08/27/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $21.30 | General |
| 08/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Neurology | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROLOGY | ||||||
| 08/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: EPILEPSY | ||||||
| 08/17/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,163 | 5,683 | $566,428 | $299,278 |
| 2022 | 17 | 1,265 | 6,243 | $609,530 | $352,747 |
| 2021 | 21 | 1,586 | 6,819 | $733,450 | $434,608 |
| 2020 | 16 | 1,569 | 6,787 | $752,795 | $417,587 |
Total Patients
5,583
Total Services
25,532
Medicare Billing
$1.5M
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 1,549 | $271,880 | $147,340 | 54.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 181 | 818 | $65,440 | $51,163 | 78.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 203 | 240 | $48,000 | $25,153 | 52.4% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2023 | 37 | 39 | $25,350 | $10,564 | 41.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 24 | 187 | $18,700 | $9,487 | 50.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 84 | 713 | $14,260 | $8,806 | 61.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $15,620 | $8,447 | 54.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 67 | $12,730 | $8,021 | 63.0% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 20 | 1,434 | $28,688 | $6,046 | 21.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 32 | 32 | $12,800 | $5,394 | 42.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 32 | 64 | $9,600 | $4,966 | 51.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 16 | 24 | $10,560 | $4,743 | 44.9% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 23 | 176 | $5,280 | $2,867 | 54.3% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 46 | 190 | $3,800 | $2,852 | 75.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 54 | 59 | $17,700 | $2,621 | 14.8% |
| 64449 | Injection by continuous infusion of anesthetic agent into lower back nerve bundle | Office | 2023 | 14 | 20 | $6,020 | $809.05 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 288 | 1,522 | $243,700 | $151,062 | 62.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 173 | 782 | $62,560 | $45,808 | 73.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 63 | 264 | $50,240 | $37,336 | 74.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 184 | 219 | $43,800 | $24,194 | 55.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 170 | $25,500 | $14,276 | 56.0% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2022 | 38 | 40 | $26,000 | $10,852 | 41.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 28 | 187 | $18,700 | $10,463 | 56.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 77 | 77 | $16,940 | $10,314 | 60.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 49 | 49 | $19,600 | $8,778 | 44.8% |
About Dr. Ram Garg, MD
Dr. Ram Garg, MD is a Neurology healthcare provider based in Taylor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164402442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ram Garg, MD has received a total of $207,610 in payments from pharmaceutical and medical device companies, with $3,160 received in 2024. These payments were reported across 2,117 transactions from 72 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($116,781).
As a Medicare-enrolled provider, Garg has provided services to 5,583 Medicare beneficiaries, totaling 25,532 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Taylor, MI
- Active Since 01/20/2006
- Last Updated 12/06/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164402442
Products in Payments
- Fycompa (Drug) $42,669
- AUBAGIO (Drug) $37,286
- UBRELVY (Drug) $31,938
- AUSTEDO (Drug) $20,234
- Betaseron (Drug) $14,932
- XCOPRI (Drug) $7,044
- APTIOM (Drug) $6,041
- QULIPTA (Drug) $5,596
- Briviact (Drug) $4,798
- TECFIDERA (Drug) $4,520
- SD809-HD (Drug) $3,887
- Vimpat (Drug) $3,116
- FYCOMPA (Drug) $2,505
- Cenobamate (Drug) $1,575
- TYSABRI (Biological) $1,390
- TROKENDI XR (Drug) $1,328
- KESIMPTA (Drug) $1,134
- INGREZZA (Drug) $744.31
- VRAYLAR (Drug) $574.45
- Aimovig (Biological) $535.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Taylor
Nawaf Murshed, M.d, M.D
Neurology — Payments: $16,988
Neurology $16,988
Dr. Faisal Ahmad, M.d, M.D
Neurology — Payments: $16,604
Neurology $16,604
Dr. Omar Ahmad, M.d, M.D
Neurology — Payments: $15,794
Neurology $15,794
Payam Sadry, D.o, D.O
Neurology — Payments: $6,486
Neurology $6,486
Ms. An Cao, Md, MD
Neurology — Payments: $804.99
Neurology $804.99
Kamala Rodrigues, M.d, M.D
Neurology — Payments: $101.78
Neurology $101.78